S. Kuila

Zinc2+ ion inhibits SARS-CoV-2 main protease and viral replication in vitro

S. Sunil, D. K. Verma, J. Thakur, 2021, bioRxiv.

Exploring the druggability of oxidized low-density lipoprotein (ox-LDL) receptor, LOX-1, a proatherogenic drug target involved in atherosclerosis.

J. Mehta, J. Jeyaraman, K. Varughese, 2022, Biochemical and biophysical research communications.